The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Selcuk Ecza Deposu Ticaret venayi AS's Revenue for the
three
months ended in Mar. 2026 was ₺51,926 Mil. Selcuk Ecza Deposu Ticaret venayi AS's average Accounts Receivable for the
three
months ended in Mar. 2026 was ₺46,238 Mil.
Hence, Selcuk Ecza Deposu Ticaret venayi AS's Receivables Turnover for the
three
months ended in Mar. 2026 was 1.12.
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Receivables Turnover Explanation
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Selcuk Ecza Deposu Ticaret venayi AS Receivables Turnover Related Terms
Selcuk Ecza Deposu Ticaret venayi AS Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selcuk Ecza Deposu Ticaret venayi AS Receivables Turnover Chart
IST:SELEC vs MCK, CAH, COR: Receivables Turnover Comparison
For the Medical Distribution subindustry, Selcuk Ecza Deposu Ticaret venayi AS's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Selcuk Ecza Deposu Ticaret venayi AS Receivables Turnover vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Selcuk Ecza Deposu Ticaret venayi AS's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Selcuk Ecza Deposu Ticaret venayi AS's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) has a Receivables Turnover of 1.12 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. According to the industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #65 out of 116 companies in the Medical Distribution industry, placing it in the top 56%.
Is Selcuk Ecza Deposu Ticaret venayi AS's Receivables Turnover too high?
Selcuk Ecza Deposu Ticaret venayi AS's current Receivables Turnover is 1.12. The Medical Distribution industry median Receivables Turnover is 4.55. Selcuk Ecza Deposu Ticaret venayi AS's value of 1.12 is 75.4% below this industry median. Based on the distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #65 out of 116 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Selcuk Ecza Deposu Ticaret venayi AS has a GF Score™ of 79/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Selcuk Ecza Deposu Ticaret venayi AS's Receivables Turnover compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Selcuk Ecza Deposu Ticaret venayi AS ranks #65 out of 116 companies for Receivables Turnover. This places Selcuk Ecza Deposu Ticaret venayi AS in the lower half of its industry. The industry median Receivables Turnover is 4.55. Selcuk Ecza Deposu Ticaret venayi AS's value of 1.12 is 75.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Distribution company?
The median Receivables Turnover among Medical Distribution companies is 4.55, based on 116 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Selcuk Ecza Deposu Ticaret venayi AS's current Receivables Turnover of 1.12 is 75.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Selcuk Ecza Deposu Ticaret venayi AS and its competitors. For the Medical Distribution industry, the median Receivables Turnover is 4.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Selcuk Ecza Deposu Ticaret venayi AS's current Receivables Turnover is 1.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Selcuk Ecza Deposu Ticaret venayi AS stock overvalued right now?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) is currently considered Significantly Overvalued. The stock's GF Value™ is ₺88.14, compared to a current price of ₺202.00 — trading 129.2% above its estimated fair value. The current Receivables Turnover is 1.12 and 75.4% below the Medical Distribution industry median of 4.55. Selcuk Ecza Deposu Ticaret venayi AS's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC), the current Receivables Turnover is 1.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Selcuk Ecza Deposu Ticaret venayi AS (IST:SELEC) Overvalued in 2026?
Based on GuruFocus' analysis, Selcuk Ecza Deposu Ticaret venayi AS stock appears to be overvalued.
The current stock price of ₺202.00 is trading 129.2% above its estimated GF Value™ of ₺88.14.
GuruFocus considers Selcuk Ecza Deposu Ticaret venayi AS to be Significantly Overvalued.
Key valuation signals for IST:SELEC:
Receivables Turnover: 1.12
GF Value™: ₺88.14 vs. price of ₺202.00 (129.2% above fair value)
Industry Position: 75.4% below the Medical Distribution median (#65 of 116)
No single metric tells the full story. See the IST:SELEC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Selcuk Ecza Deposu Ticaret venayi AS Business Description
Selcuk Ecza Deposu Ticaret ve Sanayi AS and its subsidiaries are in the business of export and import of drugs and patent medicines, medical supplies with pharmacy depot operations and also organize distribution channels between drug manufacturers, hospitals, and pharmacies. The company also distributes cosmetics, personal care, infant food, vitamins, medical and similar products.
79GF Score
Get the complete analysis for IST:SELEC
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:SELEC has been successfully added to your 
